Aleksandra Rizo
CIK: 0001766210
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNDX
Syndax Pharmaceuticals Inc
Director
Discretionary Trading P&L
Holdings
About Rizo Aleksandra
Rizo Aleksandra (SEC CIK 0001766210) files insider reports with the SEC as Director of Syndax Pharmaceuticals Inc (SNDX).
Signal8 holds 2 ownership filings by Rizo Aleksandra, all Form 4s, filed between Feb 7, 2025 and Feb 6, 2026. Those filings report 2 transactions, from Feb 5, 2025 to Feb 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rizo Aleksandra's filings is in NEW YORK, NY.
Recent filings by Rizo Aleksandra
Other insiders filing for Syndax Pharmaceuticals Inc (SNDX)
- Podlesak Dennis, Director
- Metzger Michael A, Chief Executive Officer
- Botwood Nicholas A.J., Head of R&D, CMO
- Goldan Keith A., Chief Financial Officer
- Jarrett Jennifer, Director
- Huber Martin H. Jr., Director